Clinical trial delays can result in lost revenue to drug firms of $600k – $8 million per day, not to mention additional lost lives as life-saving treatments wait in the wings . Patient recruitment is the number one cause of clinical trial delays and cost overruns, and Acurian has led the digital transformation of the recruitment process. The Company better identifies and targets appropriate populations through its 17 million patient database and population mapping algorithms .
GSK needs to carefully evaluate incorporating 3D printing in its supply chain before disrupters steal its market share.
As drug pricing policies dominate pharmaceutical headlines, the threat of economic nationalism looms even larger over AstraZeneca’s R&D pipeline.
Can wearables and electronic data capture (EDC) technologies improve clinical trials and accelerate new drug approval?